Petrovax announced today the positive results from “Long-CoV-III-21,” a randomized, double-blind, placebo-controlled trial evaluating the…




Petrovax announced today the positive results from “Long-CoV-III-21,” a randomized, double-blind, placebo-controlled trial evaluating the…
Insilico Medicine (‘Insilico’), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today…


Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with…
Investigators identified changes in immune cells that predict patient recovery, pointing to a drug that…


The new effort aims to rapidly transform academic breakthroughs into life-saving therapies for a range…
Scientists at deCODE genetics/Amgen, and their collaborators have discovered six novel genes with rare germline…